Dermatologicals in Algeria

 Published On: Oct, 2017 |    No of Pages: 17 |  Published By: Euromonitor | Format: PDF
Request Free Sample
Dermatologicals is expected to continue recording healthy value growth over the forecast period, at constant 2017 prices, pushed on by rising urbanisation and increasing awareness of these products. These factors particularly impact categories perceived more as cosmetics such as hair loss treatments and medicated shampoos. In this light, hair loss treatments and medicated shampoos are expected to remain the best performing categories in dermatologicals over the forecast period. Sales of dermatol...

Dermatologicals in Algeria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the marketís major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

DERMATOLOGICALS IN ALGERIA

Headlines
Prospects
Dermatologicals To Continue To See Strong Growth
Social Stigma Still Present for Some Categories of Dermatologicals
Medicated Shampoo and Hair Loss Treatments To Continue Driving Growth
Competitive Landscape
Saidal Algerie Maintains Its Leading Position
Innovation and New Product Launches Helps Maintain Strong Position of International Players
Sales of Dermatologicals Mainly Limited To Wealthier Consumers
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2012-2017
Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 5 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022
Executive Summary
Consumer Health Performance Slows Down Due To Rising Generics Availability
Growing Production of Domestic Generics Encouraged by the Government
Local Manufacturers of Consumer Health Products Reinforce Their Growing Shares During 2017
Chemists/pharmacies Remains the Dominant Distribution Channel for Consumer Health
Growth of Consumer Health To Be Sustained by Rising Domestic Product Supply
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 8 Life Expectancy at Birth 2012-2017
Market Data
Table 9 Sales of Consumer Health by Category: Value 2012-2017
Table 10 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 11 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 12 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 13 Distribution of Consumer Health by Format: % Value 2012-2017
Table 14 Distribution of Consumer Health by Format and Category: % Value 2017
Table 15 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.